Both in Pharmaceuticals
Vertex Pharmaceuticals vs Pfizer
Over the past year VRTX returned +31.2% and PFE returned +23.8%; their daily moves had a correlation of 0.43.
VRTX +31.2% PFE +23.8%Growth of $1, one year, split-adjusted
| Metric | VRTX | PFE |
|---|---|---|
| Price | $558.88 | $30.52 |
| Market cap | $141.65B | $173.95B |
| Today | +3.50% | +1.90% |
| 1 month | +10.3% | +8.5% |
| 6 months | +31.8% | +15.9% |
| Year to date | +23.3% | +22.6% |
| 1 year | +34.0% | +25.6% |
| Revenue growth (YoY) | +12.5% | +2.6% |
| Gross margin | 85.3% | 72.8% |
| Net margin | 33.0% | −1.6% |
| P/E (TTM) | 32.2× | 40.2× |
| Price / sales | 11.3× | 2.7× |
| Net cash | $7.85B | -$51.49B |
| Dividend yield | — | 5.64% |
| Volatility (60d) | 28.7% | 19.8% |
| Short % of float | 1.7% | 2.4% |
| Next earnings | — | Nov 3, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).